Fortvita Biologics (USA)Inc.
Fortvita Biologics (USA)Inc.
Explore linked clinical trials.7 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of IBI3042 in Healthy Adult Participants | Healthy Volunteers (HV) | Not yet recruiting | Phase 1 | 2026-09-25 | NCT07842393 | |
| A Study of IBI3003 in Subjects With Relapsed or Refractory Multiple Myeloma | Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Recruiting | Phase 1 / Phase 2 | 2026-09-25 | NCT07336472 | |
| Study of IBI3020 Treatment in Participants With Late-Stage Solid Tumors | Solid Tumors | Recruiting | Phase 1 | 2026-09-25 | NCT06963281 | |
| IBI3001 in Participants With Unresectable, Locally Advanced or Metastatic Solid Tumors | Locally Advanced Solid Tumor | Recruiting | Phase 1 | 2026-09-25 | NCT06349408 | |
| A First-in-human Study of IBI343 in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors | Locally Advanced Unresectable or Metastatic Solid Tumors | Recruiting | Phase 1 | 2026-05-04 | NCT05458219 | |
| A Phase 1, Open-label, Multicenter, Dose Escalation Study of IBI363 (PD1-IL2m) in Subjects With Advanced Solid Malignancies or Lymphomas | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Active, not recruiting | Phase 1 | 2026-03-05 | NCT05290597 | |
| A Study of IBI3032 in Healthy Participants | Healthy | Recruiting | Phase 1 | 2025-09-17 | NCT07120425 |